Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Circulation
    September 2026
  1. QI MM, Wang MM
    Letter by Qi and Wang Regarding Article, "Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome".
    Circulation. 2026;154:e394-e395.
    >> Share

  2. EVERITT IK, Mukherjee M
    Giant Left Ventricular Pseudoaneurysm Complicating Myocardial Infarction.
    Circulation. 2026;154:1052.
    >> Share

  3. LANDI A, Malik FTN, Chieffo A, Valgimigli M, et al
    Clinical Management of Myocardial Infarction.
    Circulation. 2026;154:1036-1051.
    >> Share

  4. LEONARDI S, Landi A, Valgimigli M
    Response by Leonardi et al to Letter Regarding Article, "Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome".
    Circulation. 2026;154:e396-e397.
    >> Share

  5. CONTRERAS J, Aguilar D, Bravo-Jaimes K, Cortes Y, et al
    State of Cardiovascular Disease and Stroke in Hispanic/Latino Adults in the United States: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Sep 15. doi: 10.1161/CIR.0000000000001463.
    >> Share

  6. MOCUMBI AO
    The Future of Global Cardiovascular Health Research at Circulation.
    Circulation. 2026;154:963-965.
    >> Share

  7. PURI K, Allen K, Jentzer J, Soderstrom R, et al
    Surviving Pediatric Cardiogenic Shock: Clinical Approach, Improving Outcomes, and Future Directions: A Scientific Statement From the American Heart Association.
    Circulation. 2026;154:e374-e392.
    >> Share

  8. POWELL-WILEY TM
    Partnerships That Leverage Existing Community Strengths Are Key to Improving Cardiovascular Health.
    Circulation. 2026;154:876-878.
    >> Share

  9. DE BAKKER M, Thurston AJF, Hammarsten O, Khachatryan M, et al
    Macrotroponin Complexes and Risk of Cardiovascular Events.
    Circulation. 2026 Sep 8. doi: 10.1161/CIRCULATIONAHA.126.080483.
    >> Share

  10. CHEN S, Shen S, Su W, Fu L, et al
    HNRNPK Lactylation Amplifies Inflammation and Exacerbates Myocardial Ischemia/Reperfusion Injury by Regulating Jag2 Splicing.
    Circulation. 2026 Sep 8. doi: 10.1161/CIRCULATIONAHA.126.081410.
    >> Share

  11. DINEEN EH, Haigney MC, Levine BD, Ackerman MJ, et al
    Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association.
    Circulation. 2026 Sep 3. doi: 10.1161/CIR.0000000000001476.
    >> Share

  12. DEAN JL, Murphy CE, Franzos MA, Petek BJ, et al
    Cardiovascular Disease Risk Assessment in United States Military Service Members.
    Circulation. 2026 Sep 3. doi: 10.1161/CIRCULATIONAHA.126.081464.
    >> Share

  13. TANAKA T, Kawakami R, Gaynor BJ, Williams D, et al
    Pathology of Genetic Variants in Spontaneous Coronary Artery Dissection.
    Circulation. 2026 Sep 1. doi: 10.1161/CIRCULATIONAHA.126.080495.
    >> Share

  14. CARNETHON MR
    Searching for the Uncommon: The Future of Population Science in Cardiovascular Disease.
    Circulation. 2026;154:787-788.
    >> Share

    August 2026
  15. GIUGLIANO RP, Bohula EA, Bellavia A, De Ferrari GM, et al
    Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.
    Circulation. 2026 Aug 31. doi: 10.1161/CIRCULATIONAHA.126.082436.
    >> Share

  16. OSERAN AS, Wadhera RK
    The Last Mile of Cardiovascular Prevention: Evidence, Access, and Policy.
    Circulation. 2026 Aug 31. doi: 10.1161/CIRCULATIONAHA.126.082918.
    >> Share

  17. JEEVANATHAN J, Thomas PE, Kamstrup PR, Nordestgaard BG, et al
    Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.079412.
    >> Share

  18. KHAN SS, Post WS
    Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Risk: From Young to Older Adulthood.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082984.
    >> Share

  19. GUEDON AF, Cacoub P, Carrat F, Espitia O, et al
    Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.
    Circulation. 2026 Aug 29. doi: 10.1161/CIRCULATIONAHA.126.080365.
    >> Share

  20. LAUER MS
    Coronary Artery Calcium (CAC): From Marker to Treatment Target?
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082642.
    >> Share

  21. DAVIS JW, Manson JE
    Cholecalciferol and Menaquinone Supplementation: Does Prevention of Coronary Artery Calcium Progression Mean Heart Benefit?
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082639.
    >> Share

  22. HASIFIC S, Ovrehus KA, Mejldal A, Hosbond S, et al
    Vitamin K(2) and D(3) Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial.
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082363.
    >> Share

  23. SUN G, Guo X, Zhao C, Ouyang N, et al
    Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial.
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082511.
    >> Share

  24. MILLS NL (ESC CHAIRPERSON) (UN, Kristin Newby L (ACC/AHA Co-Chairperson) (United States of America), Zaman S (WHF Co-Chairperson) (Australia), Almahmeed
    Fifth Universal Definition of Myocardial Infarction (2026): On Behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Def
    Circulation. 2026 Aug 27. doi: 10.1161/CIR.0000000000001477.
    >> Share

  25. MA L, Hu Y, Liu G, Rexrode KM, et al
    Association of Adherence to Various Dietary Patterns With Mortality Among Survivors of Myocardial Infarction: A Prospective Cohort Study.
    Circulation. 2026 Aug 25:10.1161/CIRCULATIONAHA.126.079972.
    >> Share

  26. LU B, Liu W, Ge Z, Zou J, et al
    Dual-Target Cardiac Regeneration: Controllable Nfyb/Nr3c1 Cointervention Spurs Cardiomyocyte Cytokinesis After Myocardial Infarction.
    Circulation. 2026 Aug 25. doi: 10.1161/CIRCULATIONAHA.125.079049.
    >> Share

  27. BOHULA EA, Morrow DA
    Vasoactive Agent Selection Strategies in the Management of Cardiogenic Shock.
    Circulation. 2026;154:775-784.
    >> Share

  28. SRIVASTAVA M
    The Clinical Images in Cardiovascular Medicine Section.
    Circulation. 2026;154:785.
    >> Share

  29. PLUTZKY J, Bogdanski P, Colhoun HM, Dagdelen S, et al
    Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis.
    Circulation. 2026 Aug 18. doi: 10.1161/CIRCULATIONAHA.125.074482.
    >> Share

  30. LIU Y, Chen Y, Zheng H, Li Y, et al
    ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction.
    Circulation. 2026 Aug 11. doi: 10.1161/CIRCULATIONAHA.125.078593.
    >> Share

  31. ZHOU S, Liu J, Hu M, Tian S, et al
    Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury.
    Circulation. 2026 Aug 4. doi: 10.1161/CIRCULATIONAHA.125.077971.
    >> Share

  32. SALEM AR, Kumar A, Doja J, Wally A, et al
    Loss of the Coronary Artery Disease Risk Gene LMOD1 in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis.
    Circulation. 2026 Aug 4:10.1161/CIRCULATIONAHA.126.080105.
    >> Share

  33. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
    Correction to: Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States through 2050: A Scientific Statement from the American Heart Association.
    Circulation. 2026;154:e233-e234.
    >> Share

  34. WU JC
    Perspectives on the Future of Fundamental Sciences in Cardiovascular Medicine.
    Circulation. 2026;154:425-427.
    >> Share

  35. RAISI-ESTABRAGH Z, Petersen SE, Neubauer S
    Ten Years of Scientific Discovery With the UK Biobank Cardiovascular Magnetic Resonance Imaging Study.
    Circulation. 2026;154:490-511.
    >> Share

  36. GAUDINO M, Sandner S, Bagiella E, Beckman JA, et al
    Methodologic Standards for Follow-Up Extension in Cardiovascular Trials: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Aug 3. doi: 10.1161/CIR.0000000000001458.
    >> Share

    July 2026
  37. VERGHESE D, Trujillo R, Abraham D, McClelland RL, et al
    Predictive Value of Coronary Artery Calcium Score From Nongated Chest CT Scans Compared With Gated Scans and Incidence of Cardiovascular Events.
    Circulation. 2026;154:302-312.
    >> Share

  38. NDUMELE CE, Rangaswami J, Rodriguez F
    Cardiovascular-Kidney-Metabolic Syndrome: A User's Guide to the Guidelines.
    Circulation. 2026;154:409-412.
    >> Share

  39. POWELL-WILEY TM, Williams M, Davis EM
    Telehealth for Community-Engaged Cardiovascular Care in Rural Populations.
    Circulation. 2026;154:400-404.
    >> Share

  40. HUFFMAN MD, Vijay A, Mahmoud Z
    2026 Cardiovascular-Kidney-Metabolic Guidelines: Practical Implementation Strategies.
    Circulation. 2026;154:413-415.
    >> Share

  41. LLOYD-JONES DM
    Cardiovascular-Kidney-Metabolic Syndrome: A Historic Perspective.
    Circulation. 2026;154:416-419.
    >> Share

  42. GANESH A, Sujanthan S, Muir RT, Joundi RA, et al
    Major Adverse Cognitive Events (MACE-Cog): A New "MACE" Framework for Cognitive Outcomes in Cardiovascular Diseases and Stroke.
    Circulation. 2026;154:378-394.
    >> Share

  43. RODRIGUEZ F, Langlotz CP
    Opportunistic Coronary Artery Calcium Screening: Time for Clinical Implementation.
    Circulation. 2026;154:313-315.
    >> Share

  44. BREWER LC, Joseph JJ, Cooper LA
    Cardiovascular-Kidney-Metabolic Syndrome: Population and Policy Implications: 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome.
    Circulation. 2026;154:405-408.
    >> Share

  45. STEINHAUSER ML
    Translational Cardiovascular Science for the Circulation Community.
    Circulation. 2026;154:299-300.
    >> Share

  46. MARCUS GM, Hu FB, van Dam RM, Cornelis MC, et al
    Caffeine and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Jul 20. doi: 10.1161/CIR.0000000000001454.
    >> Share

  47. JOYNT MADDOX KE
    An Integrated Ecosystem for Cardiovascular Science and Health.
    Circulation. 2026;154:85-87.
    >> Share

  48. GENTILE F, Emdin M, Clemente A
    Response by Gentile et al to Letters Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e22-e23.
    >> Share

  49. HAN QJ, Stefanescu Schmidt AC, DeFaria Yeh D
    Letter by Han et al Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e18-e19.
    >> Share

  50. LI Q, Zhang P
    Letter by Li and Zhang Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e20-e21.
    >> Share

  51. ITCHHAPORIA D, Yancy CW, Rosen SE, Mbakwem AC, et al
    Cardiovascular Health Equity: Time for a New Era of Science, Sociology, and Interventions.
    Circulation. 2026 Jul 8. doi: 10.1161/CIR.0000000000001445.
    >> Share

  52. DIDOMENICO RJ, Marrs JC, Bress AP, Denfeld QE, et al
    Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Jul 8. doi: 10.1161/CIR.0000000000001459.
    >> Share

  53. XIONG Z, Li Y, Zhang Y, Ma Z, et al
    RND3 Enhances Cardiac Glucose Metabolism Through Inhibiting ACAT1-Dependent PDHA1 Acetylation and Protects Against Ischemia-Reperfusion Injury.
    Circulation. 2026;154:37-57.
    >> Share

  54. PIGEYRE M, Gerstein HC
    Cardiovascular Risk Reduction With GLP-1 RA Drugs.
    Circulation. 2026;154:66-73.
    >> Share

    June 2026
  55. MO D, Dai H
    Why We Must Rethink Universal Lp(a) Screening as a Routine Cardiovascular Prevention Strategy.
    Circulation. 2026;153:1949-1951.
    >> Share

  56. BRANDT EJ, Carnethon MR, Watson KE
    Disparities in Cardiovascular Medicine: Evidence Is Not Enough, Policy Change Is Essential.
    Circulation. 2026;153:1877-1878.
    >> Share

  57. ZIAEIAN B, Fonarow GC
    Sisyphean Task of Cardiovascular Prevention: Real Gains, Unequal Progress.
    Circulation. 2026;153:1879-1881.
    >> Share

  58. ESSIEN UR, Joynt Maddox KE, Dusetzina SB
    Pharmacoequity and the Promise of GLP-1 Therapies in Cardiovascular Disease.
    Circulation. 2026;153:1884-1886.
    >> Share

  59. NARASIMMARAJ PR, Vyas DA, Wadhera RK
    The Cardiovascular Cost of Medicaid Cuts Under H.R. 1.
    Circulation. 2026;153:1882-1883.
    >> Share

  60. BARAC A, Guha A, Fleming TR, Bonaca M, et al
    Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Jun 15. doi: 10.1161/CIR.0000000000001417.
    >> Share

  61. SPAULDING C, Krackhardt F, Bogaerts K, Abdelaal E, et al
    Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.
    Circulation. 2026 Jun 15. doi: 10.1161/CIRCULATIONAHA.126.079033.
    >> Share

  62. ZEITOUNI M, Procopi N, Cayla G, Ferrari E, et al
    Heart Rate and Cardiovascular Outcomes in Post-Myocardial Infarction Patients Treated by beta-Blockers: A Secondary Analysis of the ABYSS Trial.
    Circulation. 2026 Jun 10. doi: 10.1161/CIRCULATIONAHA.125.078635.
    >> Share

  63. AHMED-JUSHUF F, Foley MJ, Chotai S, Rajkumar CA, et al
    Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study.
    Circulation. 2026;153:1795-1812.
    >> Share

  64. NDUMELE CE, Rodriguez F, Dixon DL, Khan SS, et al
    2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidel
    Circulation. 2026 Jun 9. doi: 10.1161/CIR.0000000000001453.
    >> Share

  65. KHAN SS, Bhave N, Blumenthal RS, Coresh J, et al
    Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Ca
    Circulation. 2026 Jun 9. doi: 10.1161/CIR.0000000000001447.
    >> Share

  66. MURPHY SA, Bellavia A
    Total Event Analysis in Cardiovascular Outcome Trials: Approaches and Interpretation.
    Circulation. 2026;153:1789-1791.
    >> Share

  67. BLANKSTEIN R, Blaha MJ, Post WS
    Should Coronary CT Angiography or Coronary Artery Calcium Testing Be Used to Guide Primary Prevention?
    Circulation. 2026;153:1691-1693.
    >> Share

    May 2026
  68. WINTERS AH, Kelly MA, Syed MG, Bergquist T, et al
    A Genome-First Study of Familial Hypercholesterolemia Comparing African and European Ancestry Individuals.
    Circulation. 2026 May 29. doi: 10.1161/CIRCULATIONAHA.126.080694.
    >> Share

  69. BARNES GD, Lech T, Allen AL
    Anticoagulation Services as a Model for Cardiovascular Medication Stewardship.
    Circulation. 2026;153:1603-1605.
    >> Share

  70. FERREIRA ZIMMER C, Marquard JM, Jabbari R, Sabbah M, et al
    Impact of Angina on Outcome After Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation: Insights From the NOTION-3 Trial.
    Circulation. 2026;153:1687-1690.
    >> Share

  71. LIU K, Yao K
    Letter by Liu and Yao Regarding Article, "Phenotypic Selectivity of Artificial Intelligence-Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction".
    Circulation. 2026;153:e1340-e1341.
    >> Share

  72. CROON PM, Khera R
    Response by Croon and Khera to Letter Regarding Article, "Phenotypic Selectivity of Artificial Intelligence-Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction".
    Circulation. 2026;153:e1342-e1343.
    >> Share

  73. MONGUILLON V, Marston NA, Bohula EA, Park JG, et al
    Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.
    Circulation. 2026 May 25. doi: 10.1161/CIRCULATIONAHA.126.080999.
    >> Share

  74. BALLIN M, Carlsson AC, Wandell P, Ahlqvist VH, et al
    Adolescent Cardiorespiratory Fitness and the Trade-Off Between Atrial Fibrillation Risk and Cardiovascular Benefits: A Nationwide Sibling-Controlled Cohort Study.
    Circulation. 2026 May 21. doi: 10.1161/CIRCULATIONAHA.125.078250.
    >> Share

  75. MAC GRORY B, Yeh RW, Beckman JA, Kamel H, et al
    Observational Comparative Research in Cardiovascular and Brain Health and Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 May 20. doi: 10.1161/CIR.0000000000001440.
    >> Share

  76. CHEN BY, Duan SZ
    Response by Chen and Duan to Letter Regarding Article, "Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells".
    Circulation. 2026;153:e1338-e1339.
    >> Share

  77. PAN Y, Ding J
    Letter by Pan and Ding Regarding Article, "Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells".
    Circulation. 2026;153:e1336-e1337.
    >> Share

  78. FISTER M, Noc M, Radsel P, Bunc M, et al
    Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI: HEPARIN-STEMI Randomized Controlled Trial.
    Circulation. 2026;153:1526-1534.
    >> Share

  79. BERGMARK BA, Bohula EA, Marston NA, Park JG, et al
    Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.
    Circulation. 2026 May 19. doi: 10.1161/CIRCULATIONAHA.126.080616.
    >> Share

  80. LALANI C, Dahabreh IJ, Cohen DJ, Kazi DS, et al
    Evaluating Cardiovascular Devices Using Observational Analyses.
    Circulation. 2026;153:1573-1592.
    >> Share

  81. DESPRES JP, Neeland IJ
    Incretin-Based Therapies and Cardiovascular Outcomes: Beyond Weight Loss.
    Circulation. 2026;153:1523-1525.
    >> Share

  82. ABBOTT JD, Benatar JR, Ballantyne CM, Jacobs AK, et al
    Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial.
    Circulation. 2026 May 18. doi: 10.1161/CIRCULATIONAHA.125.078320.
    >> Share

  83. RUEL M, Sandner S, Ponnambalam M, Brown C, et al
    Secondary Prevention After Coronary Artery Bypass Graft Surgery: 2026 Update: A Scientific Statement From the American Heart Association.
    Circulation. 2026 May 13. doi: 10.1161/CIR.0000000000001434.
    >> Share

  84. ZHANG L, Chen Y, Xu P, Zheng T, et al
    CD40-TRAF2/3/5 Signaling Promotes Cardiac Repair by Mediating Macrophage Efferocytosis After Myocardial Infarction.
    Circulation. 2026 May 7. doi: 10.1161/CIRCULATIONAHA.125.078873.
    >> Share

    April 2026
  85. ZHU K, Guo J, Liu Y, Li J, et al
    TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis.
    Circulation. 2026;153:1314-1336.
    >> Share

  86. ZHANG B, Sun A, Ge J
    Intracellular TRPM7-Mediated Zn(2+) Release: A Novel Pyroptotic Axis in Myocardial Ischemia-Reperfusion Injury.
    Circulation. 2026;153:1230-1232.
    >> Share

  87. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
    Response by Mori et al to Letter Regarding Article, "Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults".
    Circulation. 2026;153:e1128-e1129.
    >> Share

  88. LUO Y, Zhao J, Dong Q
    Letter by Luo et al Regarding Article, "Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults".
    Circulation. 2026;153:e1126-e1127.
    >> Share

  89. SHUOLIN L, Chuanyin L, Zhu M, Zhu T, et al
    Targeting E3 Ubiquitin Ligase Hrd1 Prevents Myocardial Ischemia-Reperfusion Injury Through Enhancing ALDH2 Enzymatic Activity.
    Circulation. 2026 Apr 17. doi: 10.1161/CIRCULATIONAHA.125.074399.
    >> Share

  90. ZHUANG Z, Huang J, Chi H
    Letter by Zhuang et al Regarding Article, "Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II".
    Circulation. 2026;153:e1117-e1118.
    >> Share

  91. MURCHLAND AR, Koenen KC, Lawn RB
    Response by Murchland et al to Letter Regarding Article, "Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II".
    Circulation. 2026;153:e1119-e1120.
    >> Share

  92. STEPANIAN A, Jaffe IZ
    Response by Stepanian and Jaffe to Letters Regarding Article, "Ponatinib, but Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Inf
    Circulation. 2026;153:e1113-e1114.
    >> Share

  93. ZHENG T, Yuan X, Liu H
    Letter by Zheng et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1109-e1110.
    >> Share

  94. XU X, Zhang S, Bao L
    Letter by Xu et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1111-e1112.
    >> Share

  95. LIU C, Li X
    Letter by Liu and Li Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1107-e1108.
    >> Share

  96. SCHRAMA TJ, Aengevaeren VL
    Disentangling the Relationship Between Exercise and Coronary Atherosclerosis: Wearable Training Data Are the Way Forward.
    Circulation. 2026;153:1023-1025.
    >> Share

  97. KUYUCU I, Canavar OF, Dogruer RD, Altin AD, et al
    Correction to: Abstract 4367615: The Cardiovascular Paradox of Gout Prophylaxis: A Systematic Review and Meta-analysis.
    Circulation. 2026;153:e1116.
    >> Share

  98. HOJBJERG LASSEN MC, Ostrominski JW, Claggett BL, Ndumele CE, et al
    Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study.
    Circulation. 2026 Apr 1. doi: 10.1161/CIRCULATIONAHA.125.077894.
    >> Share

    March 2026
  99. LI L
    Myocardial Infarction, Precision-Engineered T Regulatory Cells to the Rescue.
    Circulation. 2026;153:998-1000.
    >> Share

  100. ZHANG M, Qin Y, Zhou T, Liu M, et al
    Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair.
    Circulation. 2026;153:983-997.
    >> Share

  101. LICHTENSTEIN AH, Khera A, Anderson CAM, Appel LJ, et al
    2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Mar 31. doi: 10.1161/CIR.0000000000001435.
    >> Share

  102. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
    Correction to: Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026;153:e1106.
    >> Share

  103. BELLAVIA A, Murphy SA
    Competing Risks in Cardiovascular Research: A Practical Perspective.
    Circulation. 2026;153:945-947.
    >> Share

  104. HUNDEMER GL, Vaidya A
    Response by Hundemer and Vaidya to Letter Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
    Circulation. 2026;153:e1053-e1054.
    >> Share

  105. XU J, Sun Y
    Letter by Xu and Sun Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
    Circulation. 2026;153:e1052.
    >> Share

  106. VEMULAPALLI S, Pena Guerra K, Wojdyla D, Jones WS, et al
    Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080072.
    >> Share

  107. MARSTON NA, Bergmark BA, Prohaska TA, Moura FA, et al
    Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080012.
    >> Share

  108. REYNOLDS HR, Maehara A, Heydari B, Smilowitz NR, et al
    Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and Men.
    Circulation. 2026 Mar 28. doi: 10.1161/CIRCULATIONAHA.126.080234.
    >> Share

  109. HANNEMAN K, Alahmad B, Ghosh A, Khatana SAM, et al
    Nonoptimal Temperature and Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Mar 26. doi: 10.1161/CIR.0000000000001419.
    >> Share

  110. SUN S, Zhang X, Yue H, Fan C, et al
    The Aldehyde Dehydrogenase 2 rs671 Variant Enhances Platelet Activation and Arterial Thrombosis.
    Circulation. 2026;153:902-921.
    >> Share

  111. DENG KQ, Xu Z, Wang Q, Cai HH, et al
    Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction.
    Circulation. 2026;153:826-844.
    >> Share

  112. DHRUVA SS
    Role of High-Dose Influenza Vaccine in Reducing Cardiovascular Risk.
    Circulation. 2026;153:807-809.
    >> Share

  113. WATSON KE, Fonarow GC
    The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for Atherosclerotic Cardiovascular Disease Prevention and Treatment.
    Circulation. 2026 Mar 13. doi: 10.1161/CIRCULATIONAHA.126.079538.
    >> Share

  114. ZHU X, Li W, Yu J
    Letter by Zhu et al Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
    Circulation. 2026;153:e913.
    >> Share

  115. CHU L, Ma X, Chen K
    Response by Chu et al to Letter Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
    Circulation. 2026;153:e914-e915.
    >> Share

  116. ARAIZA-GARAYGORDOBIL D, Garcia-Jimenez Y, Gopar-Nieto R
    Global Rounds Mexico: Improving Cardiovascular Health Through Integration.
    Circulation. 2026;153:696-698.
    >> Share

  117. HE J, Zhu Y
    Correction to: Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
    Circulation. 2026;153:e909.
    >> Share

  118. JARR KU, Peters A, Leeper NJ
    Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention.
    Circulation. 2026;153:613-615.
    >> Share

    February 2026
  119. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
    Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 25. doi: 10.1161/CIR.0000000000001406.
    >> Share

  120. XIE J, Cheng LM, Liu K
    Letter by Xie et al Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e109-e110.
    >> Share

  121. HUANG J, Fogacci F
    Letter by Huang and Fogacci Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e111-e112.
    >> Share

  122. BERRY JD, Leonard D, Levine BD, DeFina LF, et al
    Response by Berry et al to Letter Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e113-e114.
    >> Share

  123. CARNETHON MR, Post WS, Hill JA, Al-Khatib SM, et al
    Go(ing) Red for Women and Fulfilling Our Commitment to Sex-Based Reporting of Cardiovascular Disease.
    Circulation. 2026;153:467-468.
    >> Share

  124. GRAGNANO F, Giacoppo D, Choi KH, Kimura T, et al
    Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials.
    Circulation. 2026;153:543-546.
    >> Share

  125. ROSEN SE
    Redefining Cardiovascular Medicine: The Journey From "Does Sex Matter?" to "How Does Sex Matter?".
    Circulation. 2026;153:534-535.
    >> Share

  126. BOYER TM, Barrett RB, Xiong C, Bu F, et al
    Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women.
    Circulation. 2026;153:480-492.
    >> Share

  127. LI N, Hao Z, Yang H, Cai J, et al
    CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects Against Myocardial Infarction-Induced Tissue Damage.
    Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.076426.
    >> Share

  128. DARDARI ZA, Yao Z, Zhang J, Bakoyannis G, et al
    Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration.
    Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.075327.
    >> Share

  129. BAI X, Ren R, Yuan J, Yu L, et al
    Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1.
    Circulation. 2026 Feb 11. doi: 10.1161/CIRCULATIONAHA.125.076101.
    >> Share

  130. KHAN SS, Greenland P, Hayman LL, Khera R, et al
    Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 11. doi: 10.1161/CIR.0000000000001401.
    >> Share

  131. MADHAVAN MV, Gregson J, Redfors B, Chen S, et al
    Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial.
    Circulation. 2026 Feb 10. doi: 10.1161/CIRCULATIONAHA.125.075875.
    >> Share

  132. ZHAO L, Zhao C, Wang Y
    Letter by Zhao et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e71-e72.
    >> Share

  133. HUANG Q, Jian X, Wu F
    Letter by Huang et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e69-e70.
    >> Share

  134. WU Y, Nguyen T, Wang Y, Zhou Y, et al
    Cardiomyocyte-Specific modRNA-Induced FoxM1 Overexpression Promotes Recovery From Myocardial Infarction in Adult Mammals.
    Circulation. 2026;153:463-466.
    >> Share

  135. RHEE JW, Bolton KL, Gupta D, Weeks LD, et al
    Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 10. doi: 10.1161/CIR.0000000000001404.
    >> Share

  136. VON HUNDELSHAUSEN P, Siess W, Duan R, Bohnert T, et al
    Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting.
    Circulation. 2026;153:435-456.
    >> Share

  137. ZHANG L, Iliescu C, Ferencik M, Finamore V, et al
    Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 9. doi: 10.1161/CIR.0000000000001391.
    >> Share

  138. LI X, Li X, Li CX, Feng J, et al
    TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn(2+) Homeostasis.
    Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.125.074791.
    >> Share

  139. BANGALORE S, Fearon WF, Fugar S, Dangas GD, et al
    Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association.
    Circulation. 2026;153:e25-e41.
    >> Share

  140. KOVACIC JC, Reynolds HR, Alasnag M, Blakeman JR, et al
    Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 3. doi: 10.1161/CIR.0000000000001416.
    >> Share

    January 2026
  141. PAUWELS R, Dausin C, Ruiz-Carmona S, De Bosscher R, et al
    Wearable-Derived Training Load and Coronary Atherosclerosis in Middle-Aged and Older Athletes and Physically Active Controls: A New Perspective From the Master@Heart Study.
    Circulation. 2026 Jan 29. doi: 10.1161/CIRCULATIONAHA.125.077117.
    >> Share

  142. CHANG Q, Li C, Xu Z
    An Atypical Presentation of an Occlusion Myocardial Infarction Requiring Urgent Revascularization.
    Circulation. 2026;153:282-284.
    >> Share

  143. ARMSTRONG A, Pugh D, Basu N, Dhaun N, et al
    Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
    Circulation. 2026;153:266-281.
    >> Share

  144. CHO Y, Kang D, Lim H, Lee H, et al
    Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study.
    Circulation. 2026 Jan 23. doi: 10.1161/CIRCULATIONAHA.125.078919.
    >> Share

  145. HE J, Zhu Y
    Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
    Circulation. 2026;153:185-188.
    >> Share

  146. PYRPYRIS N, Dimitriadis K, Tsioufis K
    Letter by Pyrpyris et al Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e14-e15.
    >> Share

  147. MAENG M, Thrane PG, Erlinge D, Maehara A, et al
    Response by Maeng et al to Letters Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e17-e18.
    >> Share

  148. SUN P
    Letter by Sun Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e16.
    >> Share

  149. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Correction to: Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2026;153:e19.
    >> Share

  150. MUNZEL T, Luscher T, Kramer CM, Churchwell K, et al
    Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federat
    Circulation. 2026 Jan 20. doi: 10.1161/CIRCULATIONAHA.125.079034.
    >> Share

  151. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Correction to: Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2026;153:e11.
    >> Share

  152. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Response by Sittichokkananon et al to Letter Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e6-e7.
    >> Share

  153. YANG S, Lu Y
    Letter by Yang and Lu Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e4-e5.
    >> Share

  154. ZHAO YT
    Letter by Zhao Regarding Article, "Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial".
    Circulation. 2026;153:e8-e9.
    >> Share

  155. FEARON WF, Terada K, Takahashi K, Skoda A, et al
    Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial.
    Circulation. 2026;153:7-17.
    >> Share

  156. LEONARDI S, Landi A, Zito A, Branca M, et al
    Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome.
    Circulation. 2026 Jan 6. doi: 10.1161/CIRCULATIONAHA.125.077174.
    >> Share

    December 2025
  157. GUNAWARDENE MA, Schmidt B, Peichl P, Nair D, et al
    Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias Occurring After Pulsed Field Ablation of Atrial Fibrillation.
    Circulation. 2025 Dec 25. doi: 10.1161/CIRCULATIONAHA.125.077983.
    >> Share

  158. HENRIKSEN PA
    Challenges of Clinical Trials in Cardio-Oncology: Navigating Surrogate Outcomes and Identifying Patients at Risk of Late Cardiovascular Complications.
    Circulation. 2025;152:1756-1758.
    >> Share

  159. TRAN AH, Zaidi AH, Bolger AF, Del Brutto OH, et al
    Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 16. doi: 10.1161/CIR.0000000000001390.
    >> Share

  160. XU L, Hrybouski S, Liao TE, Dong JN, et al
    Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
    Circulation. 2025;152:1608-1620.
    >> Share

  161. SHARIF A
    Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk-Reducing Intervention in Kidney Failure.
    Circulation. 2025;152:1591-1593.
    >> Share

  162. TOMCZYK M, Kraszewska I, Li G, Hayes MJ, et al
    Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction.
    Circulation. 2025;152:1586-1589.
    >> Share

  163. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Chotai S, et al
    The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
    Circulation. 2025;152:1541-1551.
    >> Share

  164. FETTERMAN JL, Chinnery PF, McClellan R, Wallace DC, et al
    Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 2. doi: 10.1161/CIR.0000000000001393.
    >> Share

  165. TSIMIKAS S, Szarek M, Cobbaert CM, Romijn F, et al
    Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes after Acute Coronary Syndrome.
    Circulation. 2025 Dec 1. doi: 10.1161/CIRCULATIONAHA.125.073855.
    >> Share

    November 2025
  166. CHEN Y
    Letter by Chen Regarding Article, "Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality".
    Circulation. 2025;152:e407.
    >> Share

  167. TULETA I, Venugopal H, O'Leary K, Zheng D, et al
    Fibroblast-Specific Loss of TGF-beta Signaling Mediates Lipomatous Metaplasia in the Infarcted Heart.
    Circulation. 2025;152:1423-1435.
    >> Share

  168. DAMLUJI AA, Nanna MG, Mason P, Lowenstern A, et al
    Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 18. doi: 10.1161/CIR.0000000000001387.
    >> Share

  169. LANDSTROM AP, Ferguson JF, James CA, Key KV, et al
    Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association.
    Circulation. 2025 Nov 13. doi: 10.1161/CIR.0000000000001385.
    >> Share

  170. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;152:e402.
    >> Share

  171. OHAYON-STECKEL L, Zhang X, Haque S, Uddin MA, et al
    miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.124.073527.
    >> Share

  172. DUDUM R, Jain SS, Mastrodicasa D, Furst A, et al
    Effects of Real-Time Notification of AI-Detected Incidental Coronary Artery Calcium on Statin Prescription: the NOTIFY-PICTURE Trial.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.078155.
    >> Share

  173. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
    High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.077801.
    >> Share

  174. SLIPCZUK L, Blankstein R, Bucciarelli-Ducci C, Braun LT, et al
    State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 10. doi: 10.1161/CIR.0000000000001394.
    >> Share

  175. LEMESLE G, Didier R, Diallo A, Dromas H, et al
    Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical Trials.
    Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.077141.
    >> Share

  176. RAPOSEIRAS ROUBIN S, Abu Assi E, Jimenez Mendez C, Minguez de la Guia E, et al
    Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
    Circulation. 2025 Nov 7. doi: 10.1161/CIRCULATIONAHA.125.075388.
    >> Share

  177. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Correction to: Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025;152:e371.
    >> Share

    October 2025
  178. RUEL M
    Introduction to the 2025 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2025;152:1187.
    >> Share

  179. DONOGHUE AJ, Auerbach M, Banerjee A, Blewer AL, et al
    Part 12: Resuscitation Education Science: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  180. HIRSCH KG, Amorim E, Coppler PJ, Drennan IR, et al
    Part 11: Post-Cardiac Arrest Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  181. DEL RIOS M, Bartos JA, Panchal AR, Atkins DL, et al
    Part 1: Executive Summary: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  182. PANCHAL AR, Bartos JA, Wyckoff MH, Drennan IR, et al
    Part 2: Evidence Evaluation and Guidelines Development: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  183. JOYNER BL JR, Dewan M, Bavare A, de Caen A, et al
    Part 6: Pediatric Basic Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  184. ELMER J, Atkins DL, Daya MR, Del Rios M, et al
    Part 3: Ethics: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  185. CAO D, Arens AM, Chow SL, Easter SR, et al
    Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  186. KLEINMAN ME, Buick JE, Huber N, Idris AH, et al
    Part 7: Adult Basic Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  187. LEE HC, Strand ML, Finan E, Illuzzi J, et al
    Part 5: Neonatal Resuscitation: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  188. DEZFULIAN C, Cabanas JG, Buckley JR, Cash RE, et al
    Part 4: Systems of Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  189. LASA JJ, Dhillon GS, Duff JP, Hayes J, et al
    Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  190. WIGGINTON JG, Agarwal S, Bartos JA, Coute RA, et al
    Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  191. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Andersen JT, et al
    Response by Windfeld-Mathiasen et al to Letter Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
    Circulation. 2025;152:e296-e297.
    >> Share

  192. KING SJ, Furst A, Fan J, Chen TP, et al
    Comparison of the Pooled Cohort and the PREVENT Cardiovascular Disease Risk Equations in the Veterans Health Administration.
    Circulation. 2025;152:1183-1185.
    >> Share

  193. KORNELIUS E
    Letter by Kornelius Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
    Circulation. 2025;152:e295.
    >> Share

  194. KOLE A, Joshi PH
    Clear as Mud: Determining the Stage of Prevention in Cardiovascular Disease.
    Circulation. 2025;152:1123-1125.
    >> Share

  195. REGAN JA, Laitner MH, Dzau VJ
    A Crossroads in Cardiovascular Medicine: Progress and Barriers to Impact.
    Circulation. 2025;152:1166-1173.
    >> Share

  196. CHEN X, Yu X, Zhong S, Sha P, et al
    ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury.
    Circulation. 2025 Oct 20. doi: 10.1161/CIRCULATIONAHA.125.075220.
    >> Share

  197. FORAKER R, Sperling L, Bratzke L, Budoff M, et al
    Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Oct 16. doi: 10.1161/CIR.0000000000001382.
    >> Share

  198. KHAN SS, Fisher SA
    Bending the Curve in Maternal Mortality: Pregnancy as a Moment for Cardiovascular Disease Prevention.
    Circulation. 2025;152:1056-1059.
    >> Share

  199. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2025;152:1044-1055.
    >> Share

  200. OREN O, Libby P
    Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice.
    Circulation. 2025;152:975-977.
    >> Share

    September 2025
  201. VONGPATANASIN W, Abraham J, Giacona JM
    Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention?
    Circulation. 2025;152:924-926.
    >> Share

  202. SECHI LA, Bulfone L, Catena C
    Letter by Sechi et al Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e265-e266.
    >> Share

  203. BHATIA HS, Tsimikas S
    Response by Bhatia and Tsimikas to Letter Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e267-e268.
    >> Share

  204. PETEK BJ, Churchill TW, Moulson N, Baggish AL, et al
    Sudden Cardiac Arrest and Death Secondary to Congenital Coronary Artery Abnormalities in Young Competitive Athletes.
    Circulation. 2025;152:971-973.
    >> Share

  205. GENTILE F, Carapellucci E, Uggenti V, Lorenzoni V, et al
    Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074198.
    >> Share

  206. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
    Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074433.
    >> Share

  207. GAN J, Zhao R, Zheng D, Peng Y, et al
    PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.
    Circulation. 2025 Sep 24. doi: 10.1161/CIRCULATIONAHA.124.072312.
    >> Share

  208. FENG S, Wang Z, Sun R
    Letter by Feng et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e239-e240.
    >> Share

  209. ZHONG Y, Lai R, Deng X
    Letter by Zhong et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e241-e242.
    >> Share

  210. JI Y, Chen LY, Zhang MJ
    Response by Ji et al to Letters Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e243-e244.
    >> Share

  211. LEVINE GN, Carney RM, Cohen BE, Dunn SL, et al
    Post-Myocardial Infarction Psychological Distress: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Sep 22. doi: 10.1161/CIR.0000000000001381.
    >> Share

  212. COUTINHO T
    The Geometry of Aging: New Angles on Cardiovascular Risk.
    Circulation. 2025;152:762-764.
    >> Share

  213. HUDED CP, Spertus JA, Jones PG, O'Brien SM, et al
    Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
    Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.073591.
    >> Share

  214. SHI F, Zheng B, Liu Y
    Letter by Shi et al Regarding Article "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e71-e72.
    >> Share

  215. NAMBI V, de Lemos JA, Ballantyne CM
    A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
    Circulation. 2025;152:567-569.
    >> Share

  216. KUEHN BM
    Microplastics Exposure Linked to Cardiovascular Disease Risk, Chronic Health Conditions.
    Circulation. 2025;152:630-631.
    >> Share

  217. SILBERNAGEL G, Wen Y, Konrad RJ
    Response by Silbernagel et al to Letters Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e73-e74.
    >> Share

  218. HUANG J
    Letter by Huang Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e69-e70.
    >> Share

  219. CROON PM, Dhingra LS, Biswas D, Oikonomou EK, et al
    Phenotypic Selectivity of Artificial Intelligence-enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction.
    Circulation. 2025 Sep 1. doi: 10.1161/CIRCULATIONAHA.125.076279.
    >> Share

    August 2025
  220. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
    >> Share

  221. CHEN BY, Zhu H, Li YL, Zhang J, et al
    Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells.
    Circulation. 2025 Aug 27. doi: 10.1161/CIRCULATIONAHA.125.074837.
    >> Share

  222. WU J, Zheng Y
    Letter by Wu and Zheng Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e67.
    >> Share

  223. HO FK, Sattar N, Welsh P
    Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e68.
    >> Share

  224. QIN D, Modanwal R, Ghazi M, Corbalan JJ, et al
    Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.
    Circulation. 2025;152:486-488.
    >> Share

  225. BERRY C, Carberry J, Dharmakumar R
    Intramyocardial Hemorrhage After Myocardial Infarction: A Prognostic Outcome for Clinical Practice and Trials.
    Circulation. 2025;152:349-351.
    >> Share

  226. VIDOT DC
    Up in Smoke: No Association Between Cannabis Smoking and Cardiovascular Events Among Older Military Veterans With Coronary Artery Disease.
    Circulation. 2025;152:366-368.
    >> Share

  227. LAWN RB, Murchland AR, Thurston RC, Marquez C, et al
    Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II.
    Circulation. 2025 Aug 11:10.1161/CIRCULATIONAHA.124.073592.
    >> Share

  228. STEPANIAN A, Travers RJ, Tesfu A, Wolter NL, et al
    Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
    Circulation. 2025 Aug 5. doi: 10.1161/CIRCULATIONAHA.125.073610.
    >> Share

  229. BECKMAN JA, Drooz AT, Farber A, Hamdan A, et al
    The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
    Circulation. 2025;152:346-348.
    >> Share

  230. TABAK RG, Kandula NR, Angell SY, Brewer LC, et al
    Implementation of Evidence-Based Behavioral Interventions for Cardiovascular Disease Prevention in Community Settings: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Aug 4. doi: 10.1161/CIR.0000000000001349.
    >> Share

    July 2025
  231. WERESKI R, Morrow DA, Mills NL
    Unstable Angina Refined.
    Circulation. 2025;152:213-216.
    >> Share

  232. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
    CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
    Circulation. 2025;152:257-273.
    >> Share

  233. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025 Jul 25. doi: 10.1161/CIRCULATIONAHA.125.073937.
    >> Share

  234. KEYHANI S, Cohen BE, Vali M, Hoggatt KJ, et al
    Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.
    Circulation. 2025 Jul 21. doi: 10.1161/CIRCULATIONAHA.124.073193.
    >> Share

  235. CARBONNEAU M, Li Y, Qu Y, Zheng Y, et al
    DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases.
    Circulation. 2025 Jul 14:10.1161/CIRCULATIONAHA.124.073181.
    >> Share

  236. BANN GG, Dos Santos M, Chen K, Tan W, et al
    Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction.
    Circulation. 2025 Jul 9. doi: 10.1161/CIRCULATIONAHA.124.072733.
    >> Share

  237. GOUPIL R, Desbiens LC, Merabtine A, Agharazii M, et al
    Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study.
    Circulation. 2025 Jul 9:10.1161/CIRCULATIONAHA.124.073507.
    >> Share

  238. HU Q, Zhang J, Luo X, Hu P, et al
    Intracellular L-PGDS-Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury.
    Circulation. 2025;152:41-57.
    >> Share

  239. HENDREN NS, Ammirati E
    Cardiovascular Effects of COVID-19: Legacy and Future Insights.
    Circulation. 2025;152:24-26.
    >> Share

  240. CUEVAS C, Kikushima-Alcantara P, Miranda JJ
    The State of Cardiovascular Care in Peru: Needs for System Strengthening.
    Circulation. 2025;152:7-10.
    >> Share

    June 2025
  241. GONG Y, Lu X, Wang X, Wang Y, et al
    Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.
    Circulation. 2025 Jun 30. doi: 10.1161/CIRCULATIONAHA.124.069737.
    >> Share

  242. DUAN Z, Lin Z
    Response by Duan and Lin to Letter Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
    Circulation. 2025;151:e1093-e1094.
    >> Share

  243. THRANE PG, Maeng M, Maehara A, Botker HE, et al
    Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.
    Circulation. 2025;151:1767-1779.
    >> Share

  244. WANG H, Zhao T, Zheng G
    Letter by Wang et al Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
    Circulation. 2025;151:e1091-e1092.
    >> Share

  245. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;151:e1098.
    >> Share

  246. BELLAVIA A, Murphy SA
    Confounders, Effect Modifiers, and Mediators: Dealing With "Third Variables" in Cardiovascular Epidemiology.
    Circulation. 2025;151:1755-1757.
    >> Share

  247. JOHNY E, Dutta P
    Targeting Extramedullary Hematopoiesis and Cardiac Immune Homing to Encourage Cardiac Healing After Myocardial Infarction.
    Circulation. 2025;151:1748-1751.
    >> Share

  248. ARNAOUT R
    From Bytes to Beats: Overcoming Conceptual and Implementation Challenges for AI in Cardiovascular Care.
    Circulation. 2025;151:1697-1698.
    >> Share

  249. GRECO M, Lombardi G, Brusasco C, Pieri M, et al
    Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial.
    Circulation. 2025 Jun 13. doi: 10.1161/CIRCULATIONAHA.125.075254.
    >> Share

  250. CAMPO G, Pavasini R
    Response by Campo and Pavasini to Letter Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1049-e1050.
    >> Share

  251. PAN D, Wu W, Chen M
    Letter by Pan et al Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1047-e1048.
    >> Share

  252. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
    Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Jun 9. doi: 10.1161/CIR.0000000000001341.
    >> Share

  253. LEE S, Hwang SH, Park S, Son Y, et al
    Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.073086.
    >> Share

  254. OBEL LM, Skovbo JS, Diederichsen ACP, Thomassen M, et al
    Aortic Aneurysm Risk and Somatic JAK2(V617F)Variation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.074002.
    >> Share

  255. CHU L, Wang R, Gross CP, Wei J, et al
    Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States.
    Circulation. 2025 Jun 3. doi: 10.1161/CIRCULATIONAHA.124.073614.
    >> Share

  256. GREGSON J, Taylor D, Owen R, Collier T, et al
    Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance.
    Circulation. 2025;151:1606-1619.
    >> Share

    May 2025
  257. SCHNEEWEISS S, Kruger N
    Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine.
    Circulation. 2025;151:1495-1497.
    >> Share

  258. BERRY C, McCartney P
    Letter by Berry and McCartney Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (The PITRI Trial)".
    Circulation. 2025;151:e1002-e1003.
    >> Share

  259. BULLUCK H, Hausenloy DJ
    Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)".
    Circulation. 2025;151:e1004-e1005.
    >> Share

  260. BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
    Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association.
    Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
    >> Share

  261. ZHANG Z, Yang X, Zhang Z
    Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e986-e987.
    >> Share

  262. REITAN C, Andell P, Hofmann R, Jernberg T, et al
    Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e988-e989.
    >> Share

  263. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Correction to: Sedentary Behavior and Light-intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025;151:e1000.
    >> Share

  264. SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
    The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
    Circulation. 2025;151:1430-1432.
    >> Share

    April 2025
  265. CLARKE R, Wright N, Lin K, Yu C, et al
    Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
    Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
    >> Share

  266. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Correction to: Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2025;151:e965-e966.
    >> Share

  267. DONG J, Yang X, Zhang W
    Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e962-e963.
    >> Share

  268. BONNESEN K, Heide-Jorgensen U, Schmidt M
    Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e964.
    >> Share

  269. ISMAHIL MA, Zhou G, Rajasekar S, Gao M, et al
    Splenic CD169(+)Tim4(+) Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.071772.
    >> Share

  270. LV H, Wang C, Liu Z, Quan M, et al
    Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.069420.
    >> Share

  271. BERRY JD, Zabad N, Kyrouac D, Leonard D, et al
    High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study.
    Circulation. 2025 Apr 21. doi: 10.1161/CIRCULATIONAHA.124.070335.
    >> Share

  272. GRAVEN LJ, Kitko L, Abshire Saylor M, Allen L, et al
    Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 17. doi: 10.1161/CIR.0000000000001323.
    >> Share

  273. STAMATAKIS E, Biswas RK, Koemel NA, Sabag A, et al
    Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality.
    Circulation. 2025;151:1063-1075.
    >> Share

  274. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025 Apr 10. doi: 10.1161/CIR.0000000000001316.
    >> Share

  275. CHEN Q, Zheng A, Xu X, Shi Z, et al
    Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2.
    Circulation. 2025;151:1024-1046.
    >> Share

  276. LAM NT, Nguyen NUN, Elhelaly WM, Hsu CC, et al
    Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility.
    Circulation. 2025;151:1009-1023.
    >> Share

  277. BENOWITZ NL
    Predicting Cardiovascular Risk With Use of Various Tobacco Products.
    Circulation. 2025;151:1006-1008.
    >> Share

  278. STEG PG, Szarek M, Jukema JW, Bhatt DL, et al
    Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of O
    Circulation. 2025;151:1047-1050.
    >> Share

  279. POWELL-WILEY TM, Brewer LC, Burke LE, Hernandez R, et al
    Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 7. doi: 10.1161/CIR.0000000000001314.
    >> Share

  280. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
    Circulation. 2025 Apr 4. doi: 10.1161/CIRCULATIONAHA.124.070632.
    >> Share

  281. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;151:e865.
    >> Share

  282. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025;151:e864.
    >> Share

  283. YU M, Cheng X
    Response by Yu and Cheng to Letter Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e769-e770.
    >> Share

  284. KAKIZAKI R, Raber L
    Letter by Kakizaki and Raber Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e767-e768.
    >> Share

    March 2025
  285. MARX N, Deanfield JE, Mann JFE, Arechavaleta R, et al
    Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
    Circulation. 2025 Mar 29. doi: 10.1161/CIRCULATIONAHA.125.074545.
    >> Share

  286. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
    Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
    Circulation. 2025 Mar 28. doi: 10.1161/CIRCULATIONAHA.125.074517.
    >> Share

  287. RYAN TD, Bates JE, Kinahan KE, Leger KJ, et al
    Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 19. doi: 10.1161/CIR.0000000000001308.
    >> Share

  288. NDUMELE CE, Ferdinand KC, Khan SS
    The Role of Race in Cardiovascular Disease Risk Prediction.
    Circulation. 2025;151:741-743.
    >> Share

  289. HULL LE, Aday AW, Bui QM, Luzum JA, et al
    Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 13. doi: 10.1161/CIR.0000000000001304.
    >> Share

  290. KURAMITSU S, Kawase Y, Shinozaki T, Domei T, et al
    Prevalence and Clinical Outcomes of Discordant Lesions Between Fractional Flow Reserve and Nonhyperemic Pressure Ratios in Clinical Practice: The J-PRIDE Registry.
    Circulation. 2025;151:672-685.
    >> Share

  291. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
    Correction to: Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
    Circulation. 2025;151:e709.
    >> Share

  292. CLAUDEL SE, Verma A
    Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review.
    Circulation. 2025;151:716-732.
    >> Share

  293. ARUNOTHAYARAJ S, Egred M, Banning AP, Brunel P, et al
    Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.
    Circulation. 2025;151:612-622.
    >> Share

  294. KOU S, Lu Z, Deng D, Ye M, et al
    Activation of Imprinted Gene PW1 Promotes Cardiac Fibrosis After Ischemic Injury.
    Circulation. 2025;151:623-639.
    >> Share

    February 2025
  295. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309.
    >> Share


  296. Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017.
    Circulation. 2025;151:e681.
    >> Share


  297. Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018.
    Circulation. 2025;151:e680.
    >> Share

  298. STARK AW, Matthey-de-l'Endroit RL, Ferroni A, Kakizaki R, et al
    Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study.
    Circulation. 2025;151:578-580.
    >> Share

  299. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Feb 20. doi: 10.1161/CIR.0000000000001297.
    >> Share

  300. ARMILLOTTA M, Bergamaschi L, Paolisso P, Belmonte M, et al
    Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2025 Feb 19. doi: 10.1161/CIRCULATIONAHA.124.070729.
    >> Share

  301. NELLIPUDI JA, Kelly B, Hardikar A
    Addressing Cardiovascular Health Inequities in Indigenous Women: Insights from Australia and Global Perspectives.
    Circulation. 2025;151:427-429.
    >> Share

  302. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Traerup Andersen J, et al
    Cardiovascular Disease in Anabolic Androgenic Steroid Users.
    Circulation. 2025 Feb 13. doi: 10.1161/CIRCULATIONAHA.124.071117.
    >> Share

  303. KIM SM, Kim S, Kim YJ, Kim WY, et al
    Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors.
    Circulation. 2025;151:421-423.
    >> Share

  304. BRENNAN SO, Kelly PJ, Gorey S, Synnott P, et al
    Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.
    Circulation. 2025;151:334-336.
    >> Share

    January 2025
  305. DAI J, Zhao J, Xu X, Chen Y, et al
    Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology?
    Circulation. 2025 Jan 31. doi: 10.1161/CIRCULATIONAHA.124.071855.
    >> Share

  306. HALL EJ, Agarwal S, Cullum CM, Sinha SS, et al
    Survivorship After Cardiogenic Shock.
    Circulation. 2025;151:257-271.
    >> Share

  307. SINGER Z, Wijeysundera HC, Qiu F, Fang J, et al
    Driving Restrictions and Incapacitation Vulnerability Evaluation After ST-Segment-Elevation Myocardial Infarction: DRIVE-STEMI Study.
    Circulation. 2025;151:282-284.
    >> Share


  308. Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
    Circulation. 2025;151:e30.
    >> Share

  309. MAURICIO R, Sharma G, Lewey J, Tompkins R, et al
    Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Jan 15. doi: 10.1161/CIR.0000000000001292.
    >> Share

  310. CHEN JZ, Liang Y, Liang B
    Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
    Circulation. 2025;151:e22.
    >> Share

  311. SUN M, He S, Hu J, Zhang Y, et al
    Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
    Circulation. 2025;151:e23.
    >> Share

  312. SIDIQI AW, Dad Zada D, Exeer NA
    Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine.
    Circulation. 2025;151:129-131.
    >> Share

  313. ROGNE T, Gill D
    Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study.
    Circulation. 2025;151:193-195.
    >> Share

  314. LIU S, Deshmukh V, Meng F, Wang Y, et al
    Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.
    Circulation. 2025;151:59-75.
    >> Share

  315. CHEW NWS, Mehta A, Goh RSJ, Zhang A, et al
    Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.
    Circulation. 2025;151:98-119.
    >> Share

    December 2024
  316. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
    Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
    Circulation. 2024;150:2046-2069.
    >> Share

  317. ZWECK E, Hassager C, Beske RP, Jensen LO, et al
    Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.
    Circulation. 2024;150:1990-2003.
    >> Share

  318. BIRKENFELD AL, Franks PW, Mohan V
    Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention.
    Circulation. 2024;150:1910-1912.
    >> Share

  319. LEWANDOWSKI AJ, Rutter MK, Collins R
    Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine.
    Circulation. 2024;150:1907-1909.
    >> Share

  320. JONE PN, Tremoulet A, Choueiter N, Dominguez SR, et al
    Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2024;150:e481-e500.
    >> Share

  321. DENNISON HIMMELFARB CR, Benowitz NL, Blank MD, Bhatnagar A, et al
    Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association.
    Circulation. 2024 Dec 3. doi: 10.1161/CIR.0000000000001293.
    >> Share

  322. LINDNER JR, Morello M
    In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development.
    Circulation. 2024;150:1885-1897.
    >> Share

  323. ARMBRUSTER S, Skali H, Wei LJ
    Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.
    Circulation. 2024;150:1823-1825.
    >> Share

    November 2024
  324. QIN D, Modanwal R, Kitsis RN
    Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction.
    Circulation. 2024;150:1812-1814.
    >> Share

  325. ZHANG W, Zhang J, Wang Z, Li T, et al
    Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury.
    Circulation. 2024;150:1791-1811.
    >> Share

  326. ITZHAKI BEN ZADOK O, Simitsis P, Jacobson C, Nadeem O, et al
    Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.
    Circulation. 2024;150:1815-1817.
    >> Share

  327. JI Y, Zhang MJ, Wang W, Norby FL, et al
    Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
    Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
    >> Share

  328. MORROW A, Young R, Abraham GR, Hoole S, et al
    Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.
    Circulation. 2024;150:1671-1683.
    >> Share


  329. Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Gui
    Circulation. 2024;150:e466.
    >> Share

  330. GIUGNI FR, Berry JD, Khera A, Shah AM, et al
    Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
    Circulation. 2024;150:1720-1731.
    >> Share

  331. HO FK, Mark PB, Lees JS, Pell JP, et al
    A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia.
    Circulation. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070454.
    >> Share

  332. GREIF R, Bray JE, Djarv T, Drennan IR, et al
    2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
    Circulation. 2024 Nov 14. doi: 10.1161/CIR.0000000000001288.
    >> Share

  333. XU X, Zhu H, Xu K
    Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e444.
    >> Share

  334. LIANG Y, Liang B
    Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e443.
    >> Share

  335. YAN Y, Nie S, Montalescot G
    Response by Yan et al to Letter Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e445-e446.
    >> Share

  336. DEZFULIAN C, McCallin TE, Bierens J, Dunne CL, et al
    2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardio
    Circulation. 2024 Nov 12. doi: 10.1161/CIR.0000000000001274.
    >> Share

  337. KIM Y, Landstrom AP, Shah SH, Wu JC, et al
    Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association.
    Circulation. 2024 Nov 11. doi: 10.1161/CIR.0000000000001296.
    >> Share

  338. MA C, Ge J, Han Y
    Global Rounds: Advancing Cardiovascular Health in China.
    Circulation. 2024 Nov 7. doi: 10.1161/CIRCULATIONAHA.124.071544.
    >> Share

  339. AVERBUCH T, Stelkia K, Van Spall HGC
    Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement.
    Circulation. 2024;150:1490-1492.
    >> Share

  340. BHATIA HS, Wandel S, Willeit P, Lesogor A, et al
    Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.
    Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.069556.
    >> Share

  341. DILLON HT, Saner NJ, Ilsley T, Kliman DS, et al
    Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.
    Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.
    >> Share

    October 2024
  342. VAN DIEPEN S, Poss J, Senaratne JM, Gage A, et al
    Mixed Cardiogenic Shock: A Proposal for Standardized Classification, a Hemodynamic Definition, and Framework for Management.
    Circulation. 2024;150:1459-1468.
    >> Share

  343. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
    Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
    Circulation. 2024;150:1478-1480.
    >> Share

  344. GRAGNANO F, van Klaveren D, Heg D, Raber L, et al
    Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072009.
    >> Share

  345. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, et al
    Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072281.
    >> Share

  346. SELLKE FW
    Bleeding After Cardiovascular Surgery: A Continuing Problem.
    Circulation. 2024;150:1324-1326.
    >> Share

  347. RUEL M, de Lemos J, Fischbein M, Hill JA, et al
    Introduction to the 2024 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2024;150:1307.
    >> Share

  348. HOFMANN C, Serafin A, Schwerdt OM, Fischer J, et al
    Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.
    Circulation. 2024;150:1248-1267.
    >> Share

  349. SILBERNAGEL G, Chen YQ, Li H, Lemen D, et al
    Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality.
    Circulation. 2024 Oct 11. doi: 10.1161/CIRCULATIONAHA.124.069272.
    >> Share

  350. KRISTENSEN JH, Hasselbalch RB, Strandkjaer N, Jorgensen N, et al
    Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans.
    Circulation. 2024;150:1187-1198.
    >> Share

  351. SINNAEVE PR, Welsh RC, Arias Mendoza A, Ristic AD, et al
    Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up.
    Circulation. 2024;150:1151-1153.
    >> Share

  352. RUEL M, Chikwe J
    Coronary Artery Bypass Grafting: Past and Future.
    Circulation. 2024;150:1067-1069.
    >> Share

  353. KNEUER JM, Grajek IA, Winkler M, Erbe S, et al
    Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing.
    Circulation. 2024;150:1101-1120.
    >> Share

    September 2024
  354. ZHAO X, Williamson T, Gong Y, Epstein JA, et al
    Immunomodulatory Therapy for Ischemic Heart Disease.
    Circulation. 2024;150:1050-1058.
    >> Share

  355. DUAN Z, Huang Z, Lei W, Zhang K, et al
    Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics.
    Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.123.065935.
    >> Share

  356. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
    Response by Giacoppo et al to Letter Regarding Article "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
    Circulation. 2024;150:e271-e272.
    >> Share

  357. ZHANG Z
    Letter by Zhang Regarding Article, "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
    Circulation. 2024;150:e269-e270.
    >> Share

  358. KOTWAL SS, Perkovic V
    Kidney Disease as a Cardiovascular Disease Priority.
    Circulation. 2024;150:975-977.
    >> Share

  359. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
    2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001285.
    >> Share

  360. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001289.
    >> Share

  361. LEE DH
    Microplastics and Cardiovascular Diseases: Importance of Coexisting Environmental Pollutants.
    Circulation. 2024;150:908-910.
    >> Share

  362. SHAH NS, Kandula NR, Commodore-Mensah Y, Morey BN, et al
    Social Determinants of Cardiovascular Health in Asian Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Sep 16. doi: 10.1161/CIR.0000000000001278.
    >> Share

  363. BUTALA NM, Bucholz EM
    Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained.
    Circulation. 2024;150:836-837.
    >> Share

  364. BEI Y, Zhu Y, Zhou J, Ai S, et al
    Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.
    Circulation. 2024;150:848-866.
    >> Share

  365. DIWAN A
    The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?
    Circulation. 2024;150:787-790.
    >> Share

  366. WYANT GA, Jiang Q, Singh M, Qayyum S, et al
    Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.
    Circulation. 2024;150:770-786.
    >> Share

  367. VOLPP KG
    Using Behavioral Science to Improve Cardiovascular Health.
    Circulation. 2024;150:743-745.
    >> Share

  368. SIMON T, Herbert BM, Brooks MM, Goodman SG, et al
    Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial.
    Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.069917.
    >> Share

  369. CAMPO G, Bohm F, Engstrom T, Smits PC, et al
    Complete vs. Culprit-Only Revascularization in Older Patients with ST-segment Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.
    Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071493.
    >> Share

    August 2024
  370. BODEN WE, De Caterina R, Kaski JC, Bairey Merz CN, et al
    Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.123.065656.
    >> Share

  371. NEUEN BL, Fletcher RA, Heath L, Perkovic A, et al
    Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071689.
    >> Share

  372. DEFILIPPIS AP, Abbott JD, Herbert BM, Bertolet MH, et al
    Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
    Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.071208.
    >> Share

  373. BONNESEN K, Heide-Jorgensen U, Christensen DH, Lash TL, et al
    Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
    Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.068613.
    >> Share

  374. DELWARDE C, Aikawa M
    Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.
    Circulation. 2024;150:706-709.
    >> Share

  375. LI J, Sun S, Zhu D, Mei X, et al
    Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.
    Circulation. 2024;150:710-723.
    >> Share

  376. YU M, Yang Y, Dong SL, Zhao C, et al
    Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069808.
    >> Share

  377. KERN MJ, Seto AH
    Does PPG, the Other Dimension to FFR, Better Predict Post-PCI Results?
    Circulation. 2024;150:598-599.
    >> Share

  378. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
    Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Circulation. 2024;150:611-621.
    >> Share

  379. KOVILAKATH A, Mauro AG, Valentine YA, Raucci FJ, et al
    SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.
    Circulation. 2024;150:622-641.
    >> Share

  380. ABBATE A, Van Tassell B, Bogin V, Markley R, et al
    Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
    Circulation. 2024;150:580-582.
    >> Share

  381. MOSLEHI JJ
    Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation.
    Circulation. 2024;150:513-515.
    >> Share

  382. MORRIS SA, Flyer JN, Yetman AT, Quezada E, et al
    Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Aug 12. doi: 10.1161/CIR.0000000000001265.
    >> Share

  383. LIN Y, Gil CH, Banno K, Yokoyama M, et al
    ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels.
    Circulation. 2024;150:451-465.
    >> Share

  384. BITTNER V
    Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.
    Circulation. 2024;150:435-438.
    >> Share

  385. JOYNT MADDOX KE
    Health Economics of Cardiovascular Disease in the United States.
    Circulation. 2024;150:419-421.
    >> Share

  386. MARTINEZ-MORATA I, Schilling K, Glabonjat RA, Domingo-Relloso A, et al
    Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2024 Aug 1. doi: 10.1161/CIRCULATIONAHA.124.069414.
    >> Share

    July 2024

  387. Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;150:e105.
    >> Share

  388. VALGIMIGLI M, Landi A, Angiolillo DJ, Baber U, et al
    Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.
    Circulation. 2024;150:317-335.
    >> Share

  389. ARMSTRONG PW
    Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries.
    Circulation. 2024;150:258-260.
    >> Share

  390. GRANT JK, Martin SS, Zhang S, Matsushita K, et al
    Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study.
    Circulation. 2024;150:250-252.
    >> Share

  391. WANG Y, Chen GC, Wang Z, Luo K, et al
    Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.
    Circulation. 2024;150:215-229.
    >> Share

  392. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2024;150:243-245.
    >> Share

  393. ADEDINSEWO D
    Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
    Circulation. 2024;150:174-176.
    >> Share

  394. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
    Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
    Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
    >> Share

  395. ABBARA S, Shaw LJ
    Past, Present, and Future of CTA.
    Circulation. 2024;150:87-90.
    >> Share

  396. FLEG JL, Huang Z, Reynolds HR, Shaw LJ, et al
    Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.
    Circulation. 2024;150:165-167.
    >> Share

  397. KUEHN BM
    Million Hearts Model Reduces Cardiovascular Events Without Increasing Care Costs.
    Circulation. 2024;150:162-164.
    >> Share

  398. REITAN C, Andell P, Alfredsson J, Erlinge D, et al
    Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study.
    Circulation. 2024 Jul 5. doi: 10.1161/CIRCULATIONAHA.124.068739.
    >> Share

  399. BERRY C, Sidik NP, McEntegart MB
    Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
    Circulation. 2024;150:e5-e6.
    >> Share

  400. NISHI T, Saito Y, Kobayashi Y
    Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
    Circulation. 2024;150:e3-e4.
    >> Share

    June 2024
  401. KIM K, Joyce BT, Zheng Y, Nannini DR, et al
    Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods.
    Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.123.067992.
    >> Share

  402. TANNU M, Kaltenbach L, Pagidipati NJ, McGuire DK, et al
    Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
    Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.124.068962.
    >> Share

  403. LIU T, Hao Y, Zhang Z, Zhou H, et al
    Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
    Circulation. 2024;149:2002-2020.
    >> Share

  404. JHA AK
    Letter by Jha Regarding Article, "Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial".
    Circulation. 2024;149:e1415-e1416.
    >> Share

  405. ZHANG S, Zhang Y, Duan X, Wang B, et al
    Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism.
    Circulation. 2024;149:1982-2001.
    >> Share

  406. SHAMSUZZAMAN S, Deaton RA, Salamon A, Doviak H, et al
    Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
    Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.123.067931.
    >> Share

  407. MIYAUCHI K, Iwata H, Nishizaki Y, Inoue T, et al
    Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
    Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.123.065520.
    >> Share


  408. Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1411.
    >> Share

  409. HUNDLEY WG
    Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis.
    Circulation. 2024;149:1859-1861.
    >> Share

  410. ANDREOTTI F, Burzotta F, Maggioni AP
    Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance".
    Circulation. 2024;149:e1312.
    >> Share

  411. GURAGAIN B, Wei Y, Zhang H, Kahn-Krell A, et al
    Implanted Human Cardiac Spheroids Electrically Couple With Infarcted Swine Myocardium.
    Circulation. 2024;149:1855-1857.
    >> Share

  412. KAZI DS, Elkind MSV, Deutsch A, Dowd WN, et al
    Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001258.
    >> Share

  413. MORAN AE, Goldman L
    Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the Unknown.
    Circulation. 2024 Jun 4. doi: 10.1161/CIRCULATIONAHA.124.070265.
    >> Share

  414. JOYNT MADDOX KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, et al
    Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001256.
    >> Share

    May 2024
  415. MEHTA LS, Churchwell K, Coleman D, Davidson J, et al
    Fostering Psychological Safety and Supporting Mental Health Among Cardiovascular Health Care Workers: A Science Advisory From the American Heart Association.
    Circulation. 2024 May 30. doi: 10.1161/CIR.0000000000001259.
    >> Share

  416. NAKAMORI S, Amyar A, Fahmy AS, Ngo LH, et al
    Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
    Circulation. 2024 May 29. doi: 10.1161/CIRCULATIONAHA.123.067107.
    >> Share

  417. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
    Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
    Circulation. 2024;149:1729-1748.
    >> Share

  418. ZHAI X, Cao S, Wang J, Qiao B, et al
    Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
    Circulation. 2024;149:1752-1769.
    >> Share


  419. Correction to: 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1218.
    >> Share

  420. SATTAR N, Neeland IJ, McGuire DK
    Obesity and Cardiovascular Disease: A New Dawn.
    Circulation. 2024;149:1621-1623.
    >> Share

  421. ZHU Q, Scherer PE
    Ceramides and Atherosclerotic Cardiovascular Disease: A Current Perspective.
    Circulation. 2024;149:1624-1626.
    >> Share

  422. BULLUCK H, Chong JH, Bryant J, Annathurai A, et al
    Effect of Cangrelor on Infarct Size in ST-Segment Elevation Myocardial Infarction Treated By Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.068938.
    >> Share

  423. COLLET C, Munhoz D, Mizukami T, Sonck J, et al
    Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.069450.
    >> Share


  424. Correction to: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
    Circulation. 2024;149:e1189-e1190.
    >> Share

  425. TANG WHW, Hazen SL
    Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.
    Circulation. 2024;149:1543-1545.
    >> Share

  426. MORRISON JT, Canonico ME, Anand SS, Patel MR, et al
    Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
    Circulation. 2024;149:1536-1539.
    >> Share

    April 2024
  427. KELHAM M, Mathur A, Jones DA
    Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1133.
    >> Share

  428. APOSTOLOS A, Karamasis GV, Tsigkas G
    Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1132.
    >> Share

  429. ZAMAN S, Edwards NC, Chew DP
    Global Rounds: Cardiovascular Care in Australia and New Zealand.
    Circulation. 2024;149:1402-1404.
    >> Share

  430. SOLOMON CG, Landrigan PJ
    Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action.
    Circulation. 2024;149:1400-1401.
    >> Share

  431. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
    Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
    Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
    >> Share

  432. GIRI J, Kaneko T
    Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease.
    Circulation. 2024;149:1339-1340.
    >> Share

  433. SHAH SH, Gerszten RE
    Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age.
    Circulation. 2024;149:1323-1325.
    >> Share

  434. SWAIN L, Bhave S, Qiao X, Reyelt L, et al
    Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
    Circulation. 2024;149:1341-1353.
    >> Share


  435. Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1128.
    >> Share

  436. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
    Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
    >> Share

  437. PATEL SM, Kang YM, Im K, Neuen BL, et al
    Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
    >> Share

  438. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
    Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
    >> Share

  439. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
    Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
    >> Share

  440. CHO L, Plutzky J, Brennan D, Louie MJ, et al
    Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
    >> Share

  441. MAEHARA A, Sugizaki Y
    Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
    Circulation. 2024;149:1087-1089.
    >> Share

  442. BLUMER V, Kanwar MK, Barnett CF, Cowger JA, et al
    Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1051-e1065.
    >> Share

  443. WU JC, Wilson BH, Fang JC, Hurwitz JL, et al
    Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
    Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553.
    >> Share

    March 2024
  444. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
    Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
    >> Share

  445. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
    Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
    Circulation. 2024;149:1033-1052.
    >> Share

  446. SERRUYS PW, Revaiah PC
    The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
    Circulation. 2024;149:973-978.
    >> Share

  447. FENG J, Li Y, Li Y, Yin Q, et al
    Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
    Circulation. 2024;149:1004-1015.
    >> Share


  448. Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
    Circulation. 2024;149:e1023.
    >> Share

  449. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
    Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
    Circulation. 2024;149:1056-1058.
    >> Share

  450. TENG Z, Ma Y, Ma X
    Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e960-e961.
    >> Share

  451. FRANGOGIANNIS NG
    Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e962-e963.
    >> Share

  452. MARANO P, Mouapi K, Kim A, Mastali M, et al
    Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
    Circulation. 2024;149:970-972.
    >> Share

  453. EVERETT BM
    The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
    Circulation. 2024;149:914-916.
    >> Share

  454. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
    A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
    Circulation. 2024;149:902-904.
    >> Share

  455. JUNCA G, Delgado V
    Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
    Circulation. 2024;149:822-824.
    >> Share

  456. HEUTS S, Myers PO, Siepe M
    Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:892-893.
    >> Share

  457. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
    Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:894-895.
    >> Share

  458. ZIMMERMANN FM, Ding VY, Fearon WF
    Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:896.
    >> Share

  459. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
    Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
    >> Share

  460. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
    Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
    Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
    >> Share

  461. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
    The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
    Circulation. 2024;149:732-733.
    >> Share

  462. RAJAGOPALAN S, Brook RD
    Cardiovascular and Planetary Health: Two Sides of the Same Planet.
    Circulation. 2024;149:729-731.
    >> Share

    February 2024
  463. CHEN Z, Zhang J, He Y
    Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:725-726.
    >> Share

  464. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
    Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:727-728.
    >> Share

  465. GAFFEY AE, Rollman BL, Burg MM
    Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component.
    Circulation. 2024;149:641-643.
    >> Share

  466. DZAU VJ, Hodgkinson CP
    RNA Therapeutics for the Cardiovascular System.
    Circulation. 2024;149:707-716.
    >> Share

  467. YAN Y, Guo J, Wang X, Wang G, et al
    Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
    Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
    >> Share

    October 2023
  468. GAUDINO M, Sandner S, An KR, Dimagli A, et al
    Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up.
    Circulation. 2023;148:1305-1315.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016